Title: |
Efficacy and Safety of Front-Line Nilotinib Treatment and Discontinuation in Older Patients (≥65 years) with Chronic Myeloid Leukemia in Chronic Phase Who Have Achieved MR4.5: Results from ENESTfreedom |
Source: |
Blood
[0006-4971]
García Gutiérrez,
Jose
yr:2020
|
|
|
|